Acquires Lysate product line from Mallinckrodt. Used in the detection of pyrogens that may be present in drugs and I.V. solutions during and after the manufacturing process, Lysate "lends itself to automated in vitro quality control procedures [and] offers advantages over the standard in vivo procedure, the rabbit fever response test," Whittaker said in a recent release. Mallinckrodt's lysate product line includes Pyrogent reagents in kit forms, Pyrosperse, a dispersing agent; and QA color lysate system, an automated system for high volume quality control testing . . . .
You may also be interested in...
The FDA has published fresh guidance taking a tougher stance on sponsor reasons for needing more time to respond to complete response letters.
Stada has named Yann Brun to become the group’s new head of global development, portfolio, regulatory and business development, replacing Robert Knerr. The move is the latest in a string of key appointments at Stada as the firm builds on a series of acquisitions and deals.
A letter from more than 60 leading public health and medical ethics experts has been sent to Pfizer's CEO Albert Bourla.